A
Anja Feldmann
Researcher at Max Planck Society
Publications - 368
Citations - 18932
Anja Feldmann is an academic researcher from Max Planck Society. The author has contributed to research in topics: The Internet & Antigen. The author has an hindex of 67, co-authored 340 publications receiving 17422 citations. Previous affiliations of Anja Feldmann include Saarland University & AT&T.
Papers
More filters
ProceedingsDOI
Proceedings of the 2003 conference on Applications, technologies, architectures, and protocols for computer communications
TL;DR: The SIGCOMM 2003 Data Communications Festival in Karlsruhe, Germany as mentioned in this paper is the most popular data conference in the world, with a focus on network security and self-similar traffic.
Journal ArticleDOI
Flexible Antigen-Specific Redirection of Human Regulatory T Cells Via a Novel Universal Chimeric Antigen Receptor System
Stefanie Koristka,Marc Cartellieri,Anja Feldmann,Claudia Arndt,Simon Loff,Irene Michalk,Roberta Aliperta,Roberta Aliperta,Malte von Bonin,Martin Bornhäuser,Armin Ehninger,Gerhard Ehninger,Michael Bachmann,Michael Bachmann +13 more
TL;DR: A more flexible universal CAR (UCAR) platform is developed that allows redirection of T cells to an in principal unrestricted number of surface antigens and pave the way towards an application of UCAR technology for a site-specific recruitment of CAR-modified Tregs into inflamed tissues aiming at re-establishing immune homeostasis.
Journal ArticleDOI
The Dagstuhl beginners guide to reproducibility for experimental networking research
Vaibhav Bajpai,Anna Brunstrom,Anja Feldmann,Wolfgang Kellerer,Aiko Pras,Henning Schulzrinne,Georgios Smaragdakis,Matthias Wählisch,Klaus Wehrle +8 more
TL;DR: In this article, the authors provide advice to researchers on designing experiments so that their work is more likely to be reproducible and to serve as a foundation for follow-on work by others.
Journal ArticleDOI
Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system.
Claudia Arndt,Anja Feldmann,Anja Feldmann,Stefanie Koristka,Marc Cartellieri,Marc Cartellieri,Maria Dimmel,Armin Ehninger,Gerhard Ehninger,Michael Bachmann,Michael Bachmann +10 more
TL;DR: A novel modular platform technology in which T cell‐recruitment and tumor‐targeting domains of conventional bispecific antibodies are split to independent components, a universal effector module (EM) and replaceable monospecific/monovalent target modules (TMs) that form highly efficient T cell-retargeting complexes should allow for simultaneous retargeting of tumor antigens.
Proceedings ArticleDOI
Detection, classification, and analysis of inter-domain traffic with spoofed source IP addresses
TL;DR: This paper proposes and evaluates a method to passively detect spoofed packets in traffic exchanged between networks in the inter-domain Internet, and applies it to classify the traffic exchange between more than 700 networks at a large European IXP.